Preventive Effects of Total Flavonoid C-Glycosides from Abrus Mollis on Nonalcoholic Fatty Liver Disease Through Activating the PPARα Signaling Pathway.

Xiao-Long Hu,Ya-Jun Niu,Mi Chen,Jia-Hao Feng,Wei Shen,Zhen-Zhou Jiang,Xiao-Qi Zhang,Wen-Cai Ye,Fei Xiong,Hao Wang
DOI: https://doi.org/10.1055/a-0895-5838
IF: 3.007
2019-01-01
Planta Medica
Abstract:Abrus pulchellus subsp. mollis (Hance) Verdc. (Leguminosae) is a well-known edible plant usually added to soups and beverages. In this study, vicenin-2 (1), isoschaftoside (2), schaftoside (3), and their enrichment fraction, total flavonoid C-glycosides, derived from the extracts of A. mollis, were firstly found to prevent nonalcoholic fatty liver disease both in vitro and in vivo. In the in vitro study, total flavonoid C-glycosides decreased the lipid accumulation in oleic acid-treated HepG2 cells. The mechanisms of total flavonoid C-glycosides are involved in the regulation of peroxisome proliferator-activated receptor a and its downstream, and the reduction of proinflammatory cytokines. In high-fat diet-induced fatty liver rats, total flavonoid C-glycosides decreased the levels of glutamicoxalacetic transaminease and glutamic-pyruvic transaminase, and decreased the lipid accumulation both in the liver and blood without affecting food intake. In addition, total flavonoid C-glycosides also increased the activities of the antioxidant enzyme system in vivo. In conclusion, total flavonoid C-glycosides are active components of A. mollis on nonalcoholic fatty liver disease, and can be used in functional food and supplements for nonalcoholic fatty liver disease prevention and treatment.
What problem does this paper attempt to address?